Company · CIK 0001737953 · SIC 2836 — Biological Products, (No Diagnostic Substances) · Nasdaq
Replimune Group, Inc. · REPL
Insider activity reported against this company. All insider holders · On EDGAR ↗
Reported at this company — common stock
| Trade | Reported (ET) | Insider | Shares | Avg price | Total | Owned after | Δ stake | Flags |
|---|---|---|---|---|---|---|---|---|
| Aug 20, 2026 GForm 4 → | Aug 24, 7:48 pm EDT | Philip Astley-SparkeDirector | 50,000 | — | — | 1,362,414 | — | |
| Aug 17, 2026 SForm 4 → | Aug 19, 6:42 pm EDT | Emily Luisa HillChief Financial Officer | 9,256 | $14.28 | $132,176 | 215,852 | −4.11% | |
| Aug 10, 2026 SForm 4 → | Aug 12, 5:07 pm EDT | Sushil PatelChief Executive Officer, Director | 39,341 | $12.97 | $510,253 | 708,151 | −5.26% | |
| Aug 10, 2026 SForm 4 → | Aug 12, 5:06 pm EDT | Emily Luisa HillChief Financial Officer | 11,448 | $12.97 | $148,481 | 225,108 | −4.84% | |
| Aug 10, 2026 SForm 4 → | Aug 12, 5:05 pm EDT | Konstantinos XynosChief Medical Officer | 11,447 | $12.97 | $148,468 | 224,215 | −4.86% | |
| Aug 10, 2026 SForm 4 → | Aug 12, 5:04 pm EDT | Andrew SchwendenmanChief Accounting Officer | 7,632 | $12.97 | $98,987 | 99,425 | −7.13% | |
| Jun 1, 2026 SForm 4 → | Jun 3, 8:30 pm EDT | Christopher SarchiChief Commercial Officer | 12,000 | $9.24 | $110,880 | 180,962 | −6.22% | 10b5-1 |
| Feb 12, 2019 JForm 4 → | Feb 14, 4:30 pm EST | Atlas Venture Fund X, L.P.10% Owner | 631,073 | — | — | 3,822,313 | — | plan? |
| Dec 13, 2018 MForm 4 → | Dec 17, 4:16 pm EST | Pamela EspositoChief Business Officer | 87,000 | $1.75 | $152,250 | 87,000 | — | plan? |
| Jul 24, 2018 PForm 4 → | Jul 26, 5:26 pm EDT | Hugo Alexander SlootwegDirector, 10% Owner | 133,333 | $15.00 | $1,999,995 | 4,721,449 | +2.91% | plan? |
| Jul 24, 2018 CForm 4 → | Jul 26, 5:26 pm EDT | Hugo Alexander SlootwegDirector, 10% Owner | 4,588,116 | — | — | 4,588,116 | — | plan? |
| Jul 24, 2018 CForm 4 → | Jul 26, 5:25 pm EDT | Atlas Venture Fund X, L.P. +210% Owner | 4,453,386 | — | — | 4,453,386 | — | plan? |
| Jul 24, 2018 CForm 4 → | Jul 26, 5:19 pm EDT | Jason P RhodesDirector | 4,453,386 | — | — | 4,453,386 | — | plan? |
| Jul 24, 2018 PForm 4 → | Jul 26, 5:16 pm EDT | Joseph P SlatteryDirector | 6,667 | $15.00 | $100,005 | 6,667 | — | plan? |
| Jul 24, 2018 PForm 4 → | Jul 26, 5:16 pm EDT | Forbion Capital Fund III Cooperatief U.A.10% Owner | 133,333 | $15.00 | $1,999,995 | 4,721,449 | +2.91% | plan? |
| Jul 24, 2018 CForm 4 → | Jul 26, 5:16 pm EDT | Forbion Capital Fund III Cooperatief U.A.10% Owner | 4,588,116 | — | — | 4,588,116 | — | plan? |
| Jul 24, 2018 PForm 4 → | Jul 26, 4:27 pm EDT | Bain Capital Life Sciences Investors, LLC +510% Owner | 500,000 | $15.00 | $7,500,000 | 2,838,968 | +21.4% | plan? |
| Jul 24, 2018 CForm 4 → | Jul 26, 4:27 pm EDT | Bain Capital Life Sciences Investors, LLC +510% Owner | 2,338,968 | — | — | 2,338,968 | — | plan? |
| Jul 24, 2018 CForm 4 → | Jul 25, 5:09 pm EDT | Omega Fund IV, L.P. +510% Owner | 4,588,116 | — | — | 4,854,783 | — | plan? |
| Jul 24, 2018 PForm 4 → | Jul 25, 5:09 pm EDT | Omega Fund IV, L.P. +510% Owner | 266,667 | $15.00 | $4,000,005 | 266,667 | — | plan? |
| Jul 24, 2018 CForm 4 → | Jul 25, 6:08 am EDT | Redmile Group, LLC +110% Owner | 779,655 | — | — | 779,655 | — | plan? |
Reported at this company — derivatives (options, RSUs, warrants)
| Trade | Reported (ET) | Insider | Shares | Avg price | Total | Owned after | Δ stake | Flags |
|---|---|---|---|---|---|---|---|---|
| Aug 11, 2026 PForm 4 → | Aug 11, 5:46 pm EDT | BAKER BROS. ADVISORS LP +5Director, 10% Owner | 2,736,340 | $12.06 | $32,999,987 | 2,609,946 | — | |
| Dec 13, 2018 MForm 4 → | Dec 17, 4:16 pm EST | Pamela EspositoChief Business Officer | 87,000 | — | — | 109,162 | — | |
| Jul 24, 2018 ACForm 4 → | Jul 26, 5:26 pm EDT | Hugo Alexander SlootwegDirector, 10% Owner | 5,098,960 | — | — | 13,500 | — | |
| Jul 24, 2018 AForm 4 → | Jul 26, 5:25 pm EDT | Philip Astley-SparkeExecutive Chairman, Director | 140,000 | — | — | 140,000 | — | |
| Jul 24, 2018 AForm 4 → | Jul 26, 5:25 pm EDT | Kapil DhingraDirector | 13,500 | — | — | 13,500 | — | |
| Jul 24, 2018 CForm 4 → | Jul 26, 5:25 pm EDT | Atlas Venture Fund X, L.P. +210% Owner | 4,453,386 | — | — | 0 | — | |
| Jul 24, 2018 AForm 4 → | Jul 26, 5:24 pm EDT | Dieter WeinandDirector | 27,000 | — | — | 27,000 | — | |
| Jul 24, 2018 AForm 4 → | Jul 26, 5:24 pm EDT | Howard KaufmanChief Medical Officer | 150,000 | — | — | 150,000 | — | |
| Jul 24, 2018 AForm 4 → | Jul 26, 5:23 pm EDT | Hyam LevitskyDirector | 27,000 | — | — | 27,000 | — | |
| Jul 24, 2018 AForm 4 → | Jul 26, 5:23 pm EDT | Pamela EspositoChief Business Officer | 70,000 | — | — | 70,000 | — | |
| Jul 24, 2018 AForm 4 → | Jul 26, 5:23 pm EDT | Stephen A GorgolChief Accounting Officer | 35,000 | — | — | 35,000 | — | |
| Jul 24, 2018 AForm 4 → | Jul 26, 5:23 pm EDT | Colin LoveChief Operating Officer | 100,000 | — | — | 100,000 | — | |
| Jul 24, 2018 ACForm 4 → | Jul 26, 5:19 pm EDT | Jason P RhodesDirector | 4,466,886 | — | — | 13,500 | — | |
| Jul 24, 2018 AForm 4 → | Jul 26, 5:16 pm EDT | Robert CoffinPresident and C.E.O., Director | 175,000 | — | — | 175,000 | — | |
| Jul 24, 2018 AForm 4 → | Jul 26, 5:16 pm EDT | Joseph P SlatteryDirector | 13,500 | — | — | 13,500 | — | |
| Jul 24, 2018 CForm 4 → | Jul 26, 5:16 pm EDT | Forbion Capital Fund III Cooperatief U.A.10% Owner | 5,085,460 | — | — | 0 | — | |
| Jul 24, 2018 CForm 4 → | Jul 26, 4:27 pm EDT | Bain Capital Life Sciences Investors, LLC +510% Owner | 235,146 | — | — | 0 | — | |
| Jul 24, 2018 CForm 4 → | Jul 25, 6:08 am EDT | Redmile Group, LLC +110% Owner | 78,382 | — | — | 0 | — | |
| Jul 19, 2018 ACForm 4 → | Jul 25, 5:09 pm EDT | Omega Fund IV, L.P. +510% Owner | 748,434 | — | — | 13,500 | — | late |